Population
Patients with coronary artery disease
Design
Review
Authors
Loading...
Flow cytometry informs platelet research in ACS; leaves open its routine clinical use for therapy monitoring.
Flow cytometry is a valuable tool for assessing platelet activation in coronary artery disease, supporting the development and monitoring of antiplatelet therapies.
Axel Matzdorff (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: